Boston, MA – According to filings with the U.S. Securities and Exchange Commission, EIP Pharma is raising $4,500,000.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Noel Donnelly played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About EIP Pharma

EIP Pharma, Inc. is a private, Cambridge, MA-based company advancing CNS-focused therapeutics to benefit patients with neurodegenerative diseases. EIP Pharma was launched in 2014 by R&D executives from the pharmaceutical and biotech industry. .

To learn more about EIP Pharma, visit http://www.eippharma.com/

Contact:
Noel Donnelly, Chief Financial Officer
617-669-8426
ndonnelly@eippharma.com
https://www.linkedin.com/in/noel-donnelly-6b6093a/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved